Strategic CDMO Diamond Animal Health is a contract development and manufacturing organization (CDMO) for USDA licensed biologicals and FDA registered pharmaceutical products across large and small animals, presenting a ready-made partner for firms seeking compliant manufacturing, scale-up, and regulatory-aligned production.

Recent Partnerships New client wins and strategic partnerships (BiomEdit, Virbac) indicate active market adoption and validation of capability, suggesting ongoing opportunities to cross-sell development, formulation, and manufacturing services to biologics and vaccines in animal health.

Acquisition Backdrop The company now operates under sister-company structure with Veterinary Pharmaceutical Solutions, following late-2023 acquisition; this implies potential for integrated supply chains, bundled services, and joint go-to-market strategies to expand contract manufacturing and development footprints.

Growth Signals Revenue in the mid-range of tens of millions, with notable investor activity (Granite Creek Capital Partners) and a visible expansion trajectory, signaling capacity to scale with new CDMO engagements and larger vaccine or biologic programs.

Industry Positioning As a leader in USDA licensed and FDA registered products for both large and small animals, Diamond Animal Health can target mid-market animal health players seeking compliant, reliable manufacturing partners, and can offer accelerated path from concept through development to production.